Anebulo Pharmaceuticals I... (ANEB)

AI Score

Unlock

1.01

-0.03 (-2.88%)

At close: Apr 17, 2025, 3:59 PM

1.01

0.00%

After-hours: Apr 17, 2025, 04:05 PM EDT

Anebulo Pharmaceuticals Cash Flow Statement

Financials in USD. Fiscal year is July - June.

Fiscal Year	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021
Period Ending	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020
Net Income	-7.67M	-7.92M	-8.2M	-9.35M	-10.49M	-11.6M	-11.73M	-11.56M	-10.64M	-7.88M	-6.83M	-33.61M	-32.29M	-31.55M	-30.25M	-1.14M	-584.98K	-256.38K
Depreciation & Amortization	119.39K	59.7K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Stock-Based Compensation	1.03M	464.48K	177.77K	805.26	224.29K	224.3K	435.99K	662.71K	564.33K	658.39K	480.66K	369.15K	291.3K	217.71K	199.95K	84.51K	37.1K	16.41K
Other Working Capital	-1.17M	135.48K	35.66K	206.14K	487K	507.07K	538.94K	878.8K	969K	279.93K	637K	75.01K	-877.32K	-1.13M	-1.56M	-792.33K	-89.64K	-65.42K
Other Non-Cash Items	802.18K	236.63K	416.02K	616.25K	471.15K	592.93K	413.43K	82.91K	167.83K	559.37K	209.88K	26.91M	26.81M	26.27M	26.63M	n/a	8.07K	4.03K
Deferred Income Tax	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Change in Working Capital	-995.02K	-178.33K	-799.26K	-436.64K	2.32K	341.67K	1.16M	1.84M	1.74M	532.48K	907.78K	76.26K	-918.85K	-804.95K	-1.45M	-710.3K	-5.16K	100.98K
Operating Cash Flow	-6.65M	-7.05M	-8.09M	-8.89M	-9.58M	-10.38M	-9.68M	-8.83M	-8.1M	-6.69M	-5.44M	-6.54M	-6.3M	-5.51M	-4.87M	-1.77M	-544.98K	-134.96K
Capital Expenditures	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cash Acquisitions	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Purchase of Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Sales Maturities Of Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Investing Acitivies	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Investing Cash Flow	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Debt Repayment	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	-8.21M	-8.21M	-8.21M	-8.21M	n/a	n/a	n/a
Other Financial Acitivies	15M	-62.35K	-62.35K	-130.51K	-130.51K	-317.08K	-264.68K	-196.53K	-196.53K	52.4K	n/a	19.78M	21.44M	21.44M	21.44M	1.66M	n/a	n/a
Financial Cash Flow	15M	-62.35K	-62.35K	-130.51K	-130.51K	-317.08K	6.38M	6.45M	6.45M	6.7M	n/a	19.78M	19.78M	19.78M	19.78M	1.66K	n/a	n/a
Net Cash Flow	8.35M	-7.12M	-8.15M	-9.02M	-9.71M	-10.69M	-3.3M	-2.38M	-1.65M	5.95K	-5.44M	13.24M	15.53M	16.32M	16.96M	282.1K	-544.98K	-134.96K
Free Cash Flow	-6.65M	-7.05M	-8.09M	-8.89M	-9.58M	-10.38M	-9.68M	-8.83M	-8.1M	-6.69M	-5.44M	-6.54M	-6.3M	-5.51M	-4.87M	-1.77M	-544.98K	-134.96K